Article Details
Retrieved on: 2024-07-11 22:40:06
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article explains the current market research on anti-CD19 antibodies, detailing clinical trials, key companies (notably Precision BioSciences and MorphoSys), and the potential impact of emerging therapies like obexelimab. This aligns with the tags covering immunology and gene therapy for lymphoma treatments.
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here